Sun Pharma Advanced Research Company has informed that a public notice by way of an advertisement has been published in all the editions (English Language) of the Financial Express dated July 19, 2025 and in Ahmedabad Edition (Gujarati Language) of the Financial Express dated July 19, 2025, after sending of electronic copy of the Annual Report for the financial year 2024- 25 including the Notice convening the 20th Annual General Meeting of the Company through email to all those shareholders whose email-ids were available. Pursuant to Regulation 30 read with Schedule III and Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, it enclosed extract from the following e-papers (all dated July 19, 2025) containing the above referred advertisement: Financial Express - Mumbai Edition (English Language); Financial Express - Ahmedabad Edition (English Language); Financial Express - Ahmedabad Edition (Gujarati Language).
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Syngene Internation. | 458.00 |
| Indegene | 529.65 |
| CMS Info Systems | 290.00 |
| JITF Infralogistics | 307.90 |
| Sagility | 44.18 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: